Allergan to Build on Body Contouring Portfolio with Latest Soliton Acquisition
The Soliton acquisition adds RESONIC technology platform for improvement in appearance of cellulite, tattoo removal, and fibrotic scars.
The Soliton acquisition adds RESONIC technology platform for improvement in appearance of cellulite, tattoo removal, and fibrotic scars.
The initial launch of the RESONIC brand for tattoo and cellulite indications is expected in Q2 of 2021.
Older women undergoing breast reconstruction after mastectomy face slightly higher risks of complications but report better psychological well-being despite lower satisfaction with breast appearance, highlighting the need to weigh age-related risks and benefits when considering surgery.